cd28 cd28 2 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
96
Structured Review
Miltenyi Biotec
cd28 cd28 2
Cd28 Cd28 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 248 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd28+cd28+2/CD28+Antibody%2C+anti-human/pmc12876840-163-24-51
Average 96 stars, based on 248 article reviews
Cd28 Cd28 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 248 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd28+cd28+2/CD28+Antibody%2C+anti-human/pmc12876840-163-24-51
Average 96 stars, based on 248 article reviews
cd28 cd28 2 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Isolation:Article Title: Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity Article Snippet: .. Naïve human CD3+ T cells were isolated from PBMC using a negative selection kit (StemCell Technologies) and activated with antibodies targeting CD3 (OKT3) and Selection:Article Title: Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity Article Snippet: .. Naïve human CD3+ T cells were isolated from PBMC using a negative selection kit (StemCell Technologies) and activated with antibodies targeting CD3 (OKT3) and Cell Culture:Article Title: Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity Article Snippet: .. Naïve human CD3+ T cells were isolated from PBMC using a negative selection kit (StemCell Technologies) and activated with antibodies targeting CD3 (OKT3) and Flow Cytometry:Article Title: Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity Article Snippet: .. Naïve human CD3+ T cells were isolated from PBMC using a negative selection kit (StemCell Technologies) and activated with antibodies targeting CD3 (OKT3) and |